Google
Trusted Resources: News & Meetings
Latest announcements and gatherings
Veterans and AL Amyloidosis
AL Amyloidosis and Agent Orange
Veterans who develop AL amyloidosis and were exposed to Agent Orange or other herbicides during military service do not have to prove a connection between their disease and service to be eligible to receive VA health care and disability compensation.
About AL amyloidosis
AL amyloidosis is a rare disease caused when amyloid proteins are abnormally deposited in tissues or organs. Primary (AL) amyloidosis is the most common form. AL amyloidosis is not a cancer, but it can occur because of some cancers.
myBinderRelated Content
-
Novel Approaches for the Management of AL AmyloidosisPurpose of Review: Light-chain-associat...
-
ISA 2020 | AL Amyloidosis: Multidisciplinary Treatment Approachhttps://www.youtube.com/watch?time_conti...
-
Alkylating Agents – ASG Webinar 2/13https://www.youtube.com/watch?v=4gUXPbOk...
-
Gastrointestinal Perforation in Light Chain Amyloidosis in the Era of Novel Agent Therapy: A Case Series and Review ...Gastrointestinal (GI) perforation is rem...
-
The SAP Scan – AL AmyloidosisSerum amyloid P component (SAP) is a nor...
-
Webinar Presentation by Jose Nativi-Nicolau on Light Chain Amyloidosis in the Hearthttps://www.youtube.com/watch?v=I1UQpBS5...
-
A Physician’s Guide to AL (Light Chain) AmyloidosisAmyloidosis is a disorder in which misfo...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
